Interestingly, the osteosarcoma T30 was the only tumor showing an amplification of CFA13 containing the oncogenes cMYC and KIT. cMYC amplifications and CFA13 gains have been detected in canine and human cancers before [76]–[78]. Here, MYC is linked to osteosarcoma.